Bone disease is one of the most common sources of morbidity in multiple myeloma (MM). Osteolytic lesions can lead to ...

A Q&A with Dennis Black, PhD, professor of epidemiology and biostatistics at UCSF, who co-led a 13-year research project behind a landmark decision by the FDA that's accelerating drug development for ...

Commonly used osteoporosis drugs were linked to a lower risk of Alzheimer’s disease and other types of dementia in a large study of older adults. Among a group of 121,492 adults age 60 or older, the ...

An experimental compound called AP503 significantly strengthened bones in mice by activating GPR133, a receptor that boosts bone formation while slowing bone loss. Because the same treatment has also ...

AI Reads Routine Chest X-Rays — and Finds a Hidden Threat to Pregnant Women’s Bones Unfractionated heparin, one of the oldest weapons in medicine’s arsenal against blood clots, may be quietly draining ...

Platelet-activating antibodies against platelet factor 4 (PF4) cause highly prothrombotic disorders with reduced platelet counts. In heparin-induced thrombocytopenia (HIT), these antibodies bind ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A new study links osteoporosis in postmenopausal women ...

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...

Loss of bone mineral density can occur for a number of reasons, including genetics, aging, hormone changes, lifestyle habits, and poor nutrition. Another major factor is certain co-occurring chronic ...

Osteoporosis is a chronic, progressive, and silent disease of the skeletal system that leads to reduced bone mineral density and altered bone microarchitecture, resulting in bone fragility and an ...